Robert Lewis

Robert Lewis is an experienced consultant with a career spanning several decades, providing expertise in immunology and biochemistry across multiple prestigious organizations. Currently engaged with HotSpot and Aminex Therapeutics since 2017 and 2013 respectively, Robert also contributes to Nimbus Therapeutics and runs a consulting practice in biosciences. Notably, Robert is a member of the Scientific Advisory Board for SymBio Pharmaceuticals and Symbio, LLC, where responsibilities include reviewing drug development candidates for licensure. Previous roles include senior positions at Aventis and sanofi-aventis, alongside consulting for major pharmaceutical companies such as Roche and Merck-Serono. Robert's education includes a Doctor of Medicine from the University of Rochester, a BA in Chemistry from Yale University, and extensive postdoctoral training at Harvard Medical School.